Filter News

Pfizer Signs Lease for the Spiral at Hudson Yards in Manhattan

Published: Apr 10, 2018

NEW YORK--(BUSINESS WIRE)-- Pfizer announced that it has signed a 20-year lease for The Spiral, an office tower being built by Tishman Speyer, at 66 Hudson Boulevard at Hudson Yards of Manhattan. As part of its 20-year lease agreement, Pfizer will relocate its global headquarters from 235 East 42nd Street to The Spiral where it will occupy 15 floors, and expects to begin moving colleagues there in 2022.

“Pfizer’s history in New York City began in 1849, and we are proud to continue our commitment to the city with our move to The Spiral in Manhattan,” said Albert Bourla, Pfizer Chief Operating Officer. “In relocating our headquarters, we sought to provide our colleagues a modern, state-of-the-art headquarters that would foster greater collaboration and innovation in a vibrant neighborhood in Manhattan.”

Alicia Glen, Deputy Mayor New York City, said, “This is another great example of a major American company choosing to keep its headquarters – and thousands of good jobs – in New York City. We thank Pfizer, a key partner in our initiative to establish New York City as the global leader in a fast growing life sciences sector — and look forward to working with them as they deepen their commitment to New York and New Yorkers.”

In addition, Pfizer made a contribution of $500,000 to the Hudson Guild, a multi-service community agency serving those who live, work, or go to school in Chelsea, with a focus on those in need. Pfizer’s donation being disbursed over five years will support Hudson Guild’s ongoing programs and services to low-income residents of Chelsea and the West Side, including free and low-income pre-k, afterschool programs, college prep, career services to young adults, mental health counseling recreational activities and meals for older adults, as well as an arts and theater program, among others.

Pfizer is currently in the process of selling its headquarters property on East 42nd Street, which it has occupied since 1961.

About Pfizer Inc.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best - known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.pfizer.com. In addition, to learn more, please visit us on www.pfizer.com and follow us on Twitter at @Pfizer and @Pfizer_News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.